^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HF158K1

    i
    Other names: HF158K1, HFK1
    Associations

    News

    Trials
    Company:
    HighField Bio
    Drug class:
    HER2 inhibitor, Topoisomerase II inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=84, Recruiting, HighField Biopharmaceuticals Corporation | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 positive • HER-2 expression • HER-2 underexpression
    |
    HF158K1
    over1year
    A Clinical Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HF158K1 in Participants With HER-2 Positive or HER-2 Low Expression Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=84, Not yet recruiting, HighField Biopharmaceuticals Corporation
    New P1 trial • Metastases
    |
    HER-2 (Human epidermal growth factor receptor 2)
    |
    HER-2 positive • HER-2 expression • HER-2 underexpression
    |
    HF158K1